A good adherence to ELN 09 recommendations in chronic myeloid leukemia (CML) treatment with imatinib, is associated with better outcomes in patients treated outside clinical trials
Services
Services
Date issued
2012Journal title
Blood
Type of content
Publicación de congreso
